Progress in companion diagnosis of colorectal cancer-Reference-Cited by-同舟云学术

Progress in companion diagnosis of colorectal cancer

Published:2023-04-08 Issue:2 Volume:2 Page:63-66
ISSN:2957-9511
Container-title:International Journal of Biology and Life Sciences
language:
Short-container-title:IJBLS

Author:

Su Quanlin

Abstract

The incidence of colorectal cancer has been increasing year by year in China in recent years. This article mainly introduces the current common companion diagnostic techniques for colorectal cancer and the monitoring of minimal residual disease and other relevant research progress in the field of colorectal cancer in vitro diagnosis, and compares them with similar detection techniques. The aim is to provide a reference for summarizing the current research status of molecular diagnosis of colorectal cancer.

Publisher

Darcy & Roy Press Co. Ltd.

Reference42 articles.

1. Xu J F, Sheng J Q. Colorectal cancer screening and its progress[J]. Chinese Journal of Gastroenterology, 2020, 25(1): 6.

2. Wang X S. Comparison of epidemiological characteristics of colorectal cancer in China and the United States and analysis of prevention and control strategies[J]. Chinese Journal of Colorectal Diseases (Electronic Edition), 2019, 8(01): 1-5.

3. National Research Center for Clinical Medicine of Digestive System Diseases (Shanghai), National Gastrointestinal Early Cancer Prevention Center Alliance, Chinese Medical Association Digestive Endoscopy Branch, et al. Expert consensus on the screening process for early colorectal cancer in China (2019, Shanghai) [J]. Chinese Journal of Digestive Endoscopy, 2019, 36(10): 709-719.

4. Yan S L, Zhang R S, Wang J H. Application and progress of targeted drug therapy for colorectal cancer[J]. World Journal of Cancer Research, 2021, 11(1): 8.

5. Schirripa M, Cohen S A, Battaglin F, et al. Biomarker-driven and molecular targeted therapies for colorectal cancers[J]. Seminars in oncology. WB Saunders, 2018, 45(3): 124-132.